Reprogramming Chromosome Ends by Functional Histone Acetylation.
W Alex MeltzerAditi GuptaPhyo Nay LinRobert A BrownDaniel S Benyamien-RoufaeilRaju KhatriAnup A MahurkarYang SongRodney J TaylorMichal ZalzmanPublished in: International journal of molecular sciences (2024)
Cancers harness embryonic programs to evade aging and promote survival. Normally, sequences at chromosome ends called telomeres shorten with cell division, serving as a countdown clock to limit cell replication. Therefore, a crucial aspect of cancerous transformation is avoiding replicative aging by activation of telomere repair programs. Mouse embryonic stem cells (mESCs) activate a transient expression of the gene Zscan4 , which correlates with chromatin de-condensation and telomere extension. Head and neck squamous cell carcinoma (HNSCC) cancers reactivate ZSCAN4, which in turn regulates the phenotype of cancer stem cells (CSCs). Our study reveals a new role for human ZSCAN4 in facilitating functional histone H3 acetylation at telomere chromatin. Next-generation sequencing indicates ZSCAN4 enrichment at telomere chromatin. These changes correlate with ZSCAN4-induced histone H3 acetylation and telomere elongation, while CRISPR/Cas9 knockout of ZSCAN4 leads to reduced H3 acetylation and telomere shortening. Our study elucidates the intricate involvement of ZSCAN4 and its significant contribution to telomere chromatin remodeling. These findings suggest that ZSCAN4 induction serves as a novel link between 'stemness' and telomere maintenance. Targeting ZSCAN4 may offer new therapeutic approaches to effectively limit or enhance the replicative lifespan of stem cells and cancer cells.
Keyphrases
- stem cells
- genome wide
- dna damage
- gene expression
- cancer stem cells
- transcription factor
- crispr cas
- copy number
- public health
- single cell
- cell therapy
- dna methylation
- endothelial cells
- embryonic stem cells
- poor prognosis
- oxidative stress
- histone deacetylase
- mesenchymal stem cells
- bone marrow
- brain injury
- blood brain barrier
- epithelial mesenchymal transition
- sensitive detection
- drug induced
- quantum dots
- cerebral ischemia
- pluripotent stem cells